Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

(SATC, PWRM, LAVA, THQI) Market Watch From!




Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that it delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (NASDAQ:ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro®, Power3's diagnostic test, and focused on Power3's Alzheimer's disease blood serum biomarkers, test and clinical validation trials.

Power3 has filed several patent applications for its NuroPro® technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, Power3 has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. Power3 intends to publish these latest findings as well.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.


THQ Inc. (Nasdaq:THQI) announced that The Biggest Loser Ultimate Workout on Kinect™ for Xbox 360® and The Biggest Loser Challenge for the Wii™ system from Nintendo, are both now available for purchase at retail outlets throughout North America. Based on the highly successful NBC television show The Biggest Loser, THQ has creatively utilized motion controls to create an interactive experience with phenomenal health benefits that users can enjoy in the comfort of their living rooms. The Biggest Loser Ultimate Workout and The Biggest Loser Challenge video games are currently available for the suggested retail prices of $49.99 and $39.99 respectively. The Biggest Loser video games are being developed and released through a license agreement with NBC Universal Television, DVD, Music and Consumer Products Group and Reveille LLC.

THQ Inc. engages in developing, publishing, and distributing interactive entertainment software for various game systems. It offers its software for home video game consoles; handheld platforms; wireless devices, such as iPhone, iTouch and iPad; and personal computers (PC), including games played online. The company also develops and publishes titles for digital distribution, as well as offers PC titles through online download stores and services.


Magma Design Automation Inc. (Nasdaq:LAVA) will conduct a live webcast and conference call to review financial results for its fiscal 2011 second quarter, which ended Oct. 31, 2010. The webcast and conference call will be Thursday, Dec. 2, 2010, at 2 p.m. PST. Magma will release second-quarter financial results after Nasdaq trading closes on Dec. 2, 2010. Rajeev Madhavan, chief executive officer; Roy E. Jewell, president and chief operating officer; and Peter S. Teshima, chief financial officer, will host the call. The live webcast will be available online at A replay of the webcast will be available on Magma’s website through Dec. 9, 2010.

Magma Design Automation, Inc. provides electronic design automation software products and related services. The company’s primary products comprise a digital integrated solution for the chip development cycle, from initial design through physical implementation. Its Talus family of products, Tekton static timing analyzer and QCP extractor, and Quartz family of sign-off and verification tools combine into one integrated chip design and verification flow and reduces design iterations.


Satcon Technology Corporation (Nasdaq:SATC) a leading provider of utility scale power conversion solutions for the renewable energy market, announced that Chief Financial Officer Don Peck will be presenting at the following investor conferences: The Stifel Nicolaus Clean Tech Conference 2010 in New York City on November 9, 2010 at 8:00 a.m. (NYSE:ET), The Jefferies 10th Annual Global Clean Technology Conference in London on November 16, 2010 at 8:00 a.m. (local time) and The Robert W. Baird 2010 Clean Technology Conference in San Francisco on November 30, 2010 at 1:45 p.m. (NYSE:PT). These presentations will include a discussion of the company’s business strategy, outlook and recent financial results. Those interested in listening to the live or archived webcasts via the Internet should log on to the “Investor Relations” section of Satcon’s website.

Satcon Technology Corporation provides a suite of utility grade power conversion solutions and services for commercial and utility scale renewable energy installations and distributed energy markets in the United States and internationally. Its renewable energy solutions include utility grade inverters for solar photovoltaic and fuel cell applications that offer modular inverters for use in connection with large, utility-scale, renewable energy power systems, such as stationary fuel cell power plants, photovoltaic power plants, and distributed power generation systems.




Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).